269 related articles for article (PubMed ID: 11381144)
1. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.
Moser TL; Kenan DJ; Ashley TA; Roy JA; Goodman MD; Misra UK; Cheek DJ; Pizzo SV
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6656-61. PubMed ID: 11381144
[TBL] [Abstract][Full Text] [Related]
2. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.
Burwick NR; Wahl ML; Fang J; Zhong Z; Moser TL; Li B; Capaldi RA; Kenan DJ; Pizzo SV
J Biol Chem; 2005 Jan; 280(3):1740-5. PubMed ID: 15528193
[TBL] [Abstract][Full Text] [Related]
3. Angiostatin binds ATP synthase on the surface of human endothelial cells.
Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
[TBL] [Abstract][Full Text] [Related]
4. Cancer research. A surprising partner for angiostatin.
Barinaga M
Science; 1999 Mar; 283(5409):1831. PubMed ID: 10206885
[No Abstract] [Full Text] [Related]
5. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase.
Chi SL; Pizzo SV
Cancer Res; 2006 Jan; 66(2):875-82. PubMed ID: 16424020
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase.
Chi SL; Wahl ML; Mowery YM; Shan S; Mukhopadhyay S; Hilderbrand SC; Kenan DJ; Lipes BD; Johnson CE; Marusich MF; Capaldi RA; Dewhirst MW; Pizzo SV
Cancer Res; 2007 May; 67(10):4716-24. PubMed ID: 17510399
[TBL] [Abstract][Full Text] [Related]
7. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells.
Redlitz A; Daum G; Sage EH
J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071
[TBL] [Abstract][Full Text] [Related]
8. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
[TBL] [Abstract][Full Text] [Related]
9. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
Wajih N; Sane DC
Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase.
Notari L; Arakaki N; Mueller D; Meier S; Amaral J; Becerra SP
FEBS J; 2010 May; 277(9):2192-205. PubMed ID: 20412062
[TBL] [Abstract][Full Text] [Related]
11. Angiostatin: a negative regulator of endothelial-dependent vasodilation.
Koshida R; Ou J; Matsunaga T; Chilian WM; Oldham KT; Ackerman AW; Pritchard KA
Circulation; 2003 Feb; 107(6):803-6. PubMed ID: 12591747
[TBL] [Abstract][Full Text] [Related]
12. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
[TBL] [Abstract][Full Text] [Related]
13. Angiostatin induces mitotic cell death of proliferating endothelial cells.
Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
[TBL] [Abstract][Full Text] [Related]
14. Endothelial progenitor cells as putative targets for angiostatin.
Ito H; Rovira II; Bloom ML; Takeda K; Ferrans VJ; Quyyumi AA; Finkel T
Cancer Res; 1999 Dec; 59(23):5875-7. PubMed ID: 10606226
[TBL] [Abstract][Full Text] [Related]
15. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
[TBL] [Abstract][Full Text] [Related]
16. Multiple forms of angiostatin induce apoptosis in endothelial cells.
Lucas R; Holmgren L; Garcia I; Jimenez B; Mandriota SJ; Borlat F; Sim BK; Wu Z; Grau GE; Shing Y; Soff GA; Bouck N; Pepper MS
Blood; 1998 Dec; 92(12):4730-41. PubMed ID: 9845539
[TBL] [Abstract][Full Text] [Related]
17. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells.
Hanford HA; Wong CA; Kassan H; Cundiff DL; Chandel N; Underwood S; Mitchell CA; Soff GA
Cancer Res; 2003 Jul; 63(14):4275-80. PubMed ID: 12874037
[TBL] [Abstract][Full Text] [Related]
18. Angiostatin upregulates E-selectin in proliferating endothelial cells.
Luo J; Lin J; Paranya G; Bischoff J
Biochem Biophys Res Commun; 1998 Apr; 245(3):906-11. PubMed ID: 9588213
[TBL] [Abstract][Full Text] [Related]
19. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.
Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y
J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108
[TBL] [Abstract][Full Text] [Related]
20. Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention?
Kenan DJ; Wahl ML
J Bioenerg Biomembr; 2005 Dec; 37(6):461-5. PubMed ID: 16691484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
